x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Sep 21, 2016 10:02 EST

Prometheon Pharma, LLC: Breakthrough product, $20B/year initial market, and expert team, with a business model providing revenue prior to product launch.

iCrowdNewswire - Sep 21, 2016

Prometheon Pharma, LLC

Prometheon logo purple 25mar13

Breakthrough product, $20B/year initial market, and expert team, with a business model providing revenue prior to product launch.

Final 20png 20clear

Company Summary

 

Featured on CNBC: www.bit.ly/ppcnbc

Patented platform technology, initial $15B/yr market. De-risked partnership model that allows big pharma to test our technology for $100k with virtually no risk to them and high margins for us. We are close to closing the first such deal with a global company.

We have delivered insulin, IGF-1 for hair regrowth, and hGH. We are outlicensing/selling the hair growth product to fund internal development in 2015.

 

Team

  •  
     
  • 2f8f399f 0168 4b47 835c 8cd8bb23f5dc
    CEO/CSO/Founder

    Harvard trained clinician/scientist with previously commercialized products.

     

  • Default avatar
    Dr. Hua Yao
    Director, R&D
    Unconfirmed

    20 years academic and industry experience in biotech/biopharm

Contact Information:

Devon Grimme

View Related News >
support